MDxHealth is trading at $0.17, up 10.61% in pre-market on November 5, 2026, amid healthcare-sector strength following the U.S. midterm election outcome.
- Healthcare stocks gained on expectations of policy support and reduced uncertainty.
- No new company announcement dated November 5 was identified; MDxHealthβs next scheduled Q3 results are November 12.
- Available market context does not establish trading volume or confirm a direct cause for the move.